Wet AMD is characterized by blood–retinal barrier leakage, parenchymal edema, and choroidal neovascularization (CNV) driven by the vascular endothelial growth factor (VEGF) (Thomas et al., 2021; Marchesi et al., 2024). The gene discussed is VEGFA; the disease is choroidal neovascularization.